
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 955 | 946 | 971 | 1261 | 1240 | 1450 |
Fund Return | -4.51% | -5.36% | -2.89% | 8.04% | 4.39% | 3.78% |
Place in category | 153 | 67 | 123 | 12 | 105 | 97 |
% in Category | 79 | 37 | 70 | 5 | 61 | 76 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 593.97B | -4.92 | 12.17 | 12.31 | ||
Fidelity Contrafund | 133.44B | -3.29 | 18.13 | 14.54 | ||
Fidelity Total Market Index Instl b | 99.37B | -5.52 | 11.34 | 11.61 | ||
Fidelity International Index Inst | 58.83B | 12.35 | 10.69 | 5.65 | ||
Fidelity Blue Chip Growth | 54.71B | -12.53 | 16.00 | 16.01 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Health Care Adm | 32.98B | 0.31 | 3.69 | 6.42 | ||
T. Rowe Price Health Sciences | 6.52B | -0.13 | 3.27 | 7.56 | ||
Fidelity Select Health Care | 6.2B | -2.20 | 4.18 | 7.04 | ||
Vanguard Health Care Inv | 5.95B | 0.29 | 3.64 | 6.36 | ||
T. Rowe Price Health Sciences I | 4.66B | -0.06 | 3.40 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AbbVie | US00287Y1091 | 23.23 | 190.07 | +2.96% | |
Amgen | US0311621009 | 7.83 | 274.76 | +3.35% | |
Gilead | US3755581036 | 7.47 | 103.82 | +7.13% | |
Regeneron Pharma | US75886F1075 | 7.34 | 575.63 | +9.07% | |
Alnylam | US02043Q1076 | 6.12 | 270.19 | +7.58% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Strong Sell |
Technical Indicators | Sell | Strong Sell | Strong Sell |
Summary | Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review